Back to Trades
Sell4
Travere Therapeutics, Inc.
TVTX
Total Value
$2.6M
Net $2.6M sold
Sales
$2.6M
3 transactions
Company Information
- Company Name
- Travere Therapeutics, Inc.
- Ticker Symbol
- TVTX
- CIK
- 0001438533
Insider Information
- Name
- Dube Eric M
- Role
- Insider
- Location
- SAN DIEGO, CA
Filing Details
- Filing Date
- Apr 15, 2026
- Transaction Date
- Apr 13, 2026
- Accession Number
- 0001763494-26-000005
- Form Type
- 4
- Net Trading Amount
- -$2.6M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Apr 13, 2026 | Common Stock | 64,000 | — | Grant/Award | — |
| Apr 15, 2026 | Common Stock | 56,815 | $41.01 | Sale | $2.3M |
| Apr 15, 2026 | Common Stock | 7,165 | $41.75 | Sale | $299.1K |
| Apr 15, 2026 | Common Stock | 20 | $42.66 | Sale | $853 |
Footnotes
- (F1)On January 31, 2025, the reporting person was granted performance restricted stock units (PSUs) which PSUs vested on April 13, 2026 upon the Issuer's confirmation that the U.S. Food and Drug Administration (FDA) had granted approval of FILSPARI (sparsentan) in FSGS.
- (F2)This sale was made pursuant to a written plan adopted on June 16, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of performance restricted stock units.
- (F3)The weighted average sale price for the transaction reported was $41.01, and the range of prices were between $40.51 and $41.51. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- (F4)The weighted average sale price for the transaction reported was $41.75, and the range of prices were between $41.52 and $42.42. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.